Jinan Babio Biotechnology Co., Ltd.

Inan Babio Biotechnology Co., Ltd. Was established in 2003. It is a professional high-tech enterprise focusing on the research and development, production and sales of in vitro diagnostic reagents. The company was successfully listed on the New Third Board in 2014 (stock name: Baibo Bio, stock code: 830774). The company has established a strict quality management system and has passed ISO9001: 2008 and ISO13485: 2003 international quality system certification. The company has international advanced automated production equipment and pharmaceutical-grade standard purification workshops. At present, it has more than 72 independent intellectual property rights, Undertook a number of national-level scientific research projects, and has 91 medical device registration certificates approved by the State Food and Drug Administration. The company′s products mainly involve virus sampling, sterile swabs, rapid detection kits, microbial detection reagents, POCT detection reagents, biochemical diagnostic reagents, diagnostic equipment such as pregnancy test products, etc. When the global epidemic broke out in 2020, Babio was actively involved in the research and development and manufacturing of sampling and testing reagents. At present, the company′s viral vectors, nasal/oral sampling swabs and rapid The test kits have been sold to more than 56 countries. The quality of the products has been recognized by medical institutions and laboratories in various countries. The company has made contributions to the global people′s fight against the epidemic. In the future, Baibo Bio will continue to work hard to help the global epidemic prevention and control. Make a new contribution!